Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZR Kezar Life Sciences Inc.

交易中 03-03 09:50:08 EST

7.10

+0.03

+0.42%

最高7.10	最低6.90	成交量2,970
今开7.07	昨收7.07	日振幅2.78%
总市值5,199万	流通市值3,331万	总股本732.32万
成交额2.09万	换手率0.06%	流通股本469.15万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":7.1,"timestamp":1772549334594,"preClose":7.07,"halted":0,"volume":2970,"delay":0,"changeRate":0.004243281471004153,"floatShares":4691522,"shares":7323156,"eps":-8.441156,"marketStatus":"交易中","change":0.03,"latestTime":"03-03 09:50:08 EST","open":7.07,"high":7.1,"low":6.9034,"amount":20942.348526,"amplitude":0.027808,"askPrice":7.06,"askSize":5,"bidPrice":7.01,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-8.441156,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772571600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":7.07,"preHourTrading":{"tag":"盘前","latestPrice":7.11,"preClose":7.07,"latestTime":"09:05 EST","volume":25,"amount":177.75,"timestamp":1772546759145,"change":0.04,"changeRate":0.005658,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":7.07,"preClose":7.07,"latestTime":"16:32 EST","volume":59,"amount":417.1,"timestamp":1772487159510,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.477199,"impliedVol":1.2986,"impliedVolPercentile":0.5259},"requestUrl":"/m/hq/s/KZR","defaultTab":"news","newsList":[{"id":"1194400922","title":"Kezar Life Sciences Inc - 将裁员70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194400922","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194400922?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:15","pubTimestamp":1763572516,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences Inc 宣布将裁员70%。此外，公司预计将面临600万美元的重组成本，并预计在2025年第四季度确认这些费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"1118313091","title":"Kezar Life Sciences公布关于Zetomipzomib在自身免疫性肝炎项目的监管更新并计划探索战略替代方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1118313091","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118313091?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:06","pubTimestamp":1760645171,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences公布关于Zetomipzomib在自身免疫性肝炎项目的监管更新并计划探索战略替代方案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2518839577","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘急速下挫5.57%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518839577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518839577?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636760,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时59分，Kezar Life Sciences, Inc.股票出现波动，股价快速跳水5.57%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6563.40%、3904.41%、1042.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2517929021","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.17%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517929021?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:59","pubTimestamp":1741208390,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时59分，Kezar Life Sciences, Inc.股票出现波动，股价急速上涨5.17%。截至发稿，该股报6.10美元/股，成交量6717股，换手率0.09%，振幅5.95%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045951963b2fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045951963b2fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2516370340","title":"Kezar Life Sciences, Inc.盘中异动 下午盘急速跳水5.60%报5.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516370340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516370340?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:14","pubTimestamp":1740766482,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时14分，Kezar Life Sciences, Inc.股票出现波动，股价大幅下挫5.60%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3170.54%、527.50%、377.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021443a25836fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301021443a25836fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2513179652","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘急速跳水5.47%报6.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513179652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513179652?lang=zh_cn&edition=full","pubTime":"2025-02-22 05:00","pubTimestamp":1740171624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日05时00分，Kezar Life Sciences, Inc.股票出现异动，股价急速下挫5.47%。截至发稿，该股报6.05美元/股，成交量7415股，换手率0.10%，振幅5.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为333.81%、257.65%、139.71%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为77.39%、70.25%、61.26%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050025abd7fe18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222050025abd7fe18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2512548598","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大涨5.42%报6.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512548598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512548598?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:30","pubTimestamp":1739975458,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时30分，Kezar Life Sciences, Inc.股票出现波动，股价大幅拉升5.42%。截至发稿，该股报6.22美元/股，成交量343股，换手率0.00%，振幅0.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Cellectar Biosciences, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为201.75%、200.71%、65.44%，振幅较大的相关个股有Azitra Inc、Cellectar Biosciences, Inc.、Kala Bio, Inc.，振幅分别为11.29%、6.05%、4.99%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223058988b3128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223058988b3128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2509256337","title":"Kezar Life Sciences, Inc.盘中异动 下午盘股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509256337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509256337?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:28","pubTimestamp":1738787325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时28分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.93%。截至发稿，该股报6.61美元/股，成交量2.6862万股，换手率0.37%，振幅4.33%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为2.29%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4685.41%、2432.32%、1778.04%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、96.79%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604284696194083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604284696194083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2500121855","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.02%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500121855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500121855?lang=zh_cn&edition=full","pubTime":"2025-01-04 04:40","pubTimestamp":1735936837,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日04时40分，Kezar Life Sciences, Inc.股票出现异动，股价急速拉升5.02%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Scorpius Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1868.52%、1757.16%、351.54%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为143.91%、123.70%、107.01%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404403795f806f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010404403795f806f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2494757896","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.00%报6.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494757896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494757896?lang=zh_cn&edition=full","pubTime":"2024-12-27 02:44","pubTimestamp":1735238654,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日02时44分，Kezar Life Sciences, Inc.股票出现波动，股价快速拉升5.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Moolec Science Sa C/Wts 涨幅较大，Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为2151.09%、472.74%、117.83%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Scisparc Ltd.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为264.57%、198.24%、131.78%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122702441498507838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122702441498507838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2492100841","title":"Kezar Life Sciences, Inc.盘中异动 下午盘急速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492100841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492100841?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:32","pubTimestamp":1734633162,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日02时32分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.25%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。消息层面，截至02时32分，《富国银行：维持Kezar Life Sciences评级》资讯为影响Kezar Life Sciences, Inc.的重要信息。该信息摘要如下：富国银行：维持kezar life sciences评级，由持股观望调整至持股观望评级,目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023242984cdc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220023242984cdc8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR"],"gpt_icon":0},{"id":"2492177350","title":"富国银行：维持Kezar Life Sciences评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492177350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492177350?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:18","pubTimestamp":1734621497,"startTime":"0","endTime":"0","summary":"富国银行：维持kezar life sciences(KZR.US)评级，由持股观望调整至持股观望评级,目标价由11.00美元调整至9.00美元。Kezar Life Sciences(KZR.US)公司简介：Kezar Life Sciences Inc是一家临床阶段生物技术公司。该公司致力于发现和开发新型小分子疗法，以治疗自身免疫和癌症领域尚未满足的需求。其产品线包括Zetomipzomib(KZR-616)和KZR-261等候选产品。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219232500a1fb6f8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219232500a1fb6f8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR"],"gpt_icon":0},{"id":"2488926280","title":"Kezar Life Sciences, Inc.盘中异动 大幅下跌6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488926280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488926280?lang=zh_cn&edition=full","pubTime":"2024-12-04 01:18","pubTimestamp":1733246302,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日01时18分，Kezar Life Sciences, Inc.股票出现波动，股价急速跳水6.48%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Jupiter Neurosciences Inc、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为145.88%、137.68%、124.09%，振幅较大的相关个股有Jupiter Neurosciences Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.75%、69.23%、59.76%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204011822abf345ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204011822abf345ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2484391651","title":"Kezar Life Sciences, Inc.2024财年第三财季实现净利润-20.31百万美元，同比增加12.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484391651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484391651?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010422,"startTime":"0","endTime":"0","summary":"11月19日，Kezar Life Sciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.31百万美元，同比增加12.08%；其中营业收入为0.00美元，每股基本收益为-2.78美元。机构评级：截至2024年11月19日，当前有2家机构对Kezar Life Sciences, Inc.目标价做出预测，其中目标均价为14.50美元，其中最低目标价为11.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180048abcedf0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180048abcedf0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR"],"gpt_icon":0},{"id":"2479708006","title":"Kezar Life Sciences, Inc.盘中异动 大幅下跌9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479708006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479708006?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:32","pubTimestamp":1730381563,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时32分，Kezar Life Sciences, Inc.股票出现波动，股价急速跳水9.89%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.85%。其相关个股中，Aerovate Therapeutics, Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为192.44%、186.36%、145.93%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Aerovate Therapeutics, Inc.，振幅分别为21.98%、14.49%、9.59%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324395bd9c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121324395bd9c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2479478376","title":"Kezar Life Sciences, Inc.盘中异动 股价大跌5.12%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479478376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479478376?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295080,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分，Kezar Life Sciences, Inc.股票出现波动，股价急速下跌5.12%。截至发稿，该股报7.12美元/股，成交量7791股，换手率0.11%，振幅0.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tiziana Life Sciences Ltd涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1673.30%、97.73%、13.89%，振幅较大的相关个股有Tharimmune, Inc.、Cormedix Inc.、Dogwood Therapeutics, Inc.，振幅分别为20.69%、8.86%、6.95%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213124971a33a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213124971a33a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2479289161","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大跌5.49%报0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479289161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479289161?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:13","pubTimestamp":1730211230,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时13分，Kezar Life Sciences, Inc.股票出现波动，股价快速下跌5.49%。截至发稿，该股报0.730美元/股，成交量20.0846万股，换手率0.28%，振幅5.63%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029221350971a2f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029221350971a2f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2477860612","title":"Kezar Life Sciences, Inc.盘中异动 临近午盘股价大跌5.04%报0.782美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477860612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477860612?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:36","pubTimestamp":1729524989,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时36分，Kezar Life Sciences, Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报0.782美元/股，成交量7.5158万股，换手率0.10%，振幅4.54%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为6393.24%、3062.65%、1353.30%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123363098e3d932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123363098e3d932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2476112717","title":"Kezar Life Sciences, Inc.盘中异动 大幅跳水5.00%报0.850美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476112717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476112717?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:30","pubTimestamp":1729171857,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时30分，Kezar Life Sciences, Inc.股票出现波动，股价快速下跌5.00%。截至发稿，该股报0.850美元/股，成交量32.7704万股，换手率0.45%，振幅0.56%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721305898e3cfd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721305898e3cfd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2474225801","title":"Kezar Life Sciences, Inc.股价拉升22.97% 市值涨1525.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225801?lang=zh_cn&edition=full","pubTime":"2024-10-09 21:31","pubTimestamp":1728480661,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日21时31分，Kezar Life Sciences, Inc.股票出现异动，股价急速上涨22.97%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Gri Bio, Inc.较为活跃，换手率分别为605.03%、68.34%、33.65%，振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为19.51%、10.92%、5.56%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213101959af608&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009213101959af608&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","KZR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":0.0459},{"period":"1month","weight":0.1647},{"period":"3month","weight":0.1496},{"period":"6month","weight":0.8175},{"period":"1year","weight":0.2382},{"period":"ytd","weight":0.124}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kezar Life Sciences, Inc.于2015年2月19日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，开发新型小分子疗法，用于治疗免疫介导疾病和癌症中未满足的需求。该公司正在推进两个利用细胞功能不同调节因子的药物开发计划：第一个针对负责免疫系统细胞中蛋白质降解并驱动免疫细胞功能的许多关键方面的免疫蛋白酶体，第二个针对Sec61转座子。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.084723},{"month":2,"riseRate":0.75,"avgChangeRate":0.08063},{"month":3,"riseRate":0.375,"avgChangeRate":-0.082486},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.082421},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.16242},{"month":6,"riseRate":0.428571,"avgChangeRate":0.046939},{"month":7,"riseRate":0.25,"avgChangeRate":-0.059399},{"month":8,"riseRate":0.5,"avgChangeRate":-0.012192},{"month":9,"riseRate":0.375,"avgChangeRate":0.031351},{"month":10,"riseRate":0.375,"avgChangeRate":0.02054},{"month":11,"riseRate":0.75,"avgChangeRate":0.152848},{"month":12,"riseRate":0.5,"avgChangeRate":0.034727}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}